TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of participants adhering to oral PrEP as measured using the MEMS cap and MedAmigo system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of enrolled participants reporting side effects as recorded on the clinical and adverse event forms
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Sustained Clinical Improvement of at Least 2 Points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the average daily pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t1/2 (Hour)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Total Point Motion (MTPM in mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for exam room vs waiting room
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in anterior lamina cribrosa depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluating Respiratory Symptoms (E-RS) in COPD Total Score-COPD Cohort Only
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Exacerbations of Chronic Pulmonary Disease Tool (EXACT) Event Rate-COPD Cohort Only
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Postoperative significant AR (SAR)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with a CSBM of 3 or more per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number Of Participants Experiencing Treatment-emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Total Immediate Recall (ISLT-TIR)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in nutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with reported adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in muscle strength scale grade of affected limb muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sensory recovery scale grade of affected dermatomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients with successful ex vivo results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with successful treatment decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Arterial hypertension associated with tracheal extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in heart rate (HR) associated with tracheal extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Fasting FGF19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Vaccine prevention of malaria infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Distribution and localization of 18F-FLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: frequencies of urination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Wibergs Centre-Edge Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total female condom failure
Endpoint domain: Adverse events/effects
Primary endpoint: Wormald Surgical Field Grading Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visibility and ease of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Outcome of pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: fetal development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: adequate growth for GA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: perinatal complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change of body fat percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of muscular strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to relapse of alcohol abuse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum force peak in knee flexion and extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ED90 of Metaraminol to treat hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under curve (AUC) of urinary pregnandiol glucuronide (Pdg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Assessment of global disorders in patients with breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Alteration of aqueous flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plasma Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WOMAC index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Lequesne's functional index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postprandial glucose incremental area under the curve (iAUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucose variability (mean amplitude glycemic excursions)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Nail Psoriasis Severity Index (NAPSI) Score for Target Fingernail
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New Bone Formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcriptomic changes in human skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: histological features of drug-induced liver injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: clinical features of drug-induced liver injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Sacral angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients Achieving Less Than or Equal to 2 RTOG Score At Visit 9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in concentrations of specific metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Probing pocket depth changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients progression-free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average daily sedentary minutes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pharmacokinetics of bumetanide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of bumetanide
Endpoint domain: Adverse events/effects
Primary endpoint: White blood cell count with differential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: gait under dual-task condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pronosupination strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with major cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Measurement of Anti Xa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in CIPN symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodynamic Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Echocardiographic Parameters of left and right heart function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in low density lipoprotein cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety of P27A with adjuvants
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of knee osteoarthritis care
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Transit time through the colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of fast bowel movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Overall Participant Survival at One Year Post Kidney Transplant
Endpoint domain: Mortality/survival
Primary endpoint: Overall Kidney Graft Survival at One Year Post-Transplant
Endpoint domain: Mortality/survival
Primary endpoint: Change in albumin excretion over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Patient Benefit Index (PBI) outcome score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in IKDC subjective score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Degree of craving
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: maximally tolerated dose of imexon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toxicity of imexon
Endpoint domain: Adverse events/effects
Primary endpoint: response and progression free survival
Endpoint domain: Mortality/survival
Primary endpoint: CPR Compression Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Change Over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reactogenicity Events
Endpoint domain: Adverse events/effects
Primary endpoint: taste intensity ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width of Joint at 12 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width of Bone Bridging at 12 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width of Any Fixation Hardware at 12 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of RNF213 gene variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HR-MRI findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mayo Clinic Performance Index for The Elbow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quick DASH Outcome Measure
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to addition of new treatment for type 2 diabetes
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cases of myopericarditis
Endpoint domain: Adverse events/effects
Primary endpoint: triglyceride lowering effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mobility Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankylosing Spondylitis Disease Activity Scale - Disease Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve over the dosing interval on multiple dosing (AUC[0-τ])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average steady-state concentration (Css,av)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed concentration at steady-state (Css,max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adverse events during study period
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Histological Clearance achieved of BCC treated lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Subjects Whose Blood Pressure Reached Target Blood Pressure Reduction Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NIH-stroke scale (NIHSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Myocardial Inflammation/Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean difference of total number of LNs retrieved during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FLNs identification rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angiographic Late Lumen Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pharmacokinetics measured by plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in alcohol consumption from baseline to 7-weeks post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in ART adherence from baseline to 7-weeks post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: GI Mucosal Lesions Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical Symptoms Using The Gastrointestinal Symptom Rating Scale (GSRS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Average Daily Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Early detection of delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of Tidal Volume (Vt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Short term seropositivity rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anti-measles antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall Local-Regional Tumor Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in salivary cortisol at the operative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in salivary cortisol at the first day after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in the intensity of endometriosis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Protein Synthesis (MPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscle Protein Breakdown (MPB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Left Ventricular (LV) Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in The McGill Pain Scale - Short Form (SF-MPQ) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Rated Wrist Evaluation (PRWE) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of one puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Change in Inches of Total Circumference Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real-time imaging of cutaneous histopathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Molecular changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Dimensions of Identity Development
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Identity from an Eriksonian Perspective
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Illness Centrality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Self-Identity after Cancer
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of men with metastatic castration resistant prostate cancer (mCRPC) of Xofigo use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of being women of Xofigo use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of being children of Xofigo use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-Treatment Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days until third available appointment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diagnostic accuracy of wireless colon capsule endoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction of opioids and analgesics usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Occurrence of Severe Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With T-cell Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Liver Iron Concentration (LIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Saccadic Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of Patients With Response to Depsipeptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of care gaps closed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Gross Motor Function Measure Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Temporomandibular joint opening index (TOI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pursuit eye movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood Volume Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: longest duration of negative urine and breath samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of child maltreatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: rate of occurrence of dose-limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety profile of Halifax produced FDG
Endpoint domain: Adverse events/effects
Primary endpoint: Immediate failure rate (residual disease in hysterectomy specimen)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients identified with metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Relatives' Perception of Dignity and Respect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adequate Support in Patients' Last Days of Life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Event-related-pupil-dilations (ERPDs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse Wave Velocity (cfPWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events (TEAEs) Related to Standard Hematology
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events (TEAEs) Related to Fat Soluble Vitamins (Vitamin A, D, & E)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events (TEAEs) Related to Lipid Panel
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events (TEAEs) Related to Thyroid Hormone Panel
Endpoint domain: Adverse events/effects
Primary endpoint: Improved Mobility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Opioid Analgesic Requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient sedation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and nature of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Culture Positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: urinary bladder displacement in millimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change score in Liking/wanting of the e-cigarette
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Fluzoparib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes